Viatris (VTRS) Interest Expenses (2019 - 2026)
Viatris (VTRS) posted quarterly Interest Expenses of $1.2 billion for Q1 2026, down 2.19% year-over-year from $1.2 billion in Q1 2025, and up 908.36% quarter-over-quarter from $119.6 million in Q4 2025.
Viatris (VTRS) Interest Expenses (2019 - 2026) Analysis & Trends
Viatris' Interest Expenses history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Interest Expenses fell 2.19% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 2.19% YoY), while the FY2025 annual figure was $1.4 billion, up 16.75% from the prior year.
- Interest Expenses for Q1 2026 stood at $1.2 billion, up from $119.6 million in the prior quarter.
- The five-year high for Interest Expenses was $2.1 billion in Q1 2022, with the low at $119.6 million in Q3 2025.
- The 5-year median for Interest Expenses is $197.2 million (2022), against an average of $877.5 million.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses plunged 93.15% in 2023, then soared 747.05% in 2025.
- Viatris' Interest Expenses stood at $197.2 million in 2022, then decreased by 28.55% to $140.9 million in 2023, then slipped by 14.69% to $120.2 million in 2024, then fell by 0.5% to $119.6 million in 2025, then soared by 908.36% to $1.2 billion in 2026.
- Business Quant data shows VTRS's Interest Expenses at $1.2 billion in Q1 2026, $119.6 million in Q4 2025, and $119.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.21 Bn |
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 119.60 Mn |
| Dec 31, 2025 | 119.60 Mn |
| Sep 30, 2025 | 119.60 Mn |
| Sep 30, 2025 | 119.60 Mn |
| Jun 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.23 Bn |
| Mar 31, 2025 | 1.23 Bn |
| Dec 31, 2024 | 120.20 Mn |
| Dec 31, 2024 | 120.20 Mn |
| Sep 30, 2024 | 145.60 Mn |
| Sep 30, 2024 | 145.60 Mn |
| Jun 30, 2024 | 145.80 Mn |
| Jun 30, 2024 | 145.80 Mn |
| Mar 31, 2024 | 1.77 Bn |
| Mar 31, 2024 | 1.77 Bn |